As part of a system that impacts cell growth, the VDAC1–HK complex represents a remarkable target for cancer therapy (see The Interaction of VDAC1 with Hexokinase Regulates Cell Bioenergetics and Apoptosis). This evidence concerns the gene HK1 and cancer.